What a new medicine costs the regions.
Five years, four regions, low, base and high. Built only on published figures: patient numbers, list prices and DRG tariffs.
Sign in to continue
This tool is for current Helios clients only.
Access is by invitation. If you're a client and don't have an account yet, get in touch and we'll send you one.
Your account doesn't have access to this tool
If you think this is wrong, let us know and we'll sort it out.
1 · Eligible patients per region
Patients who could get the medicine
Saved models in your account
2 · Uptake per year
Uptake, %
Base is the main case. Low and high give the range the Medicines Council asks for.
3 · Price of the new medicine
Price per patient-year, DKK
Low and high can be, for example, an expected discount or a higher dose.
4 · Current treatment replaced
Enter 0 if the new medicine is given on top of current treatment.
Hospital activity that goes with it
5 · Hospital activity
Activity the medicine adds
Add-on tariffs
Activity the medicine avoids
Effect on avoided activity, % of base
The low scenario counts on more avoided activity, the high scenario on less.
6 · Result and export
Net impact per year
Bar: base. Line: low to high.Budget impact
Net budget impact = cost to the regions if the medicine is recommended, minus the cost if it is not.